desipramine has been researched along with agi-5198 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Y; Ma, T; Pusch, S; von Deimling, A; Xu, Y; Yang, L; Zha, X; Zhu, Q; Zou, F | 1 |
| Gu, Y; Hua, J; Ma, T; Pusch, S; von Deimling, A; Xu, Y; Yang, L; Zha, X; Zhu, Q; Zou, F | 1 |
2 other study(ies) available for desipramine and agi-5198
| Article | Year |
|---|---|
Design, synthesis and biological activity of 3-pyrazine-2-yl-oxazolidin-2-ones as novel, potent and selective inhibitors of mutant isocitrate dehydrogenase 1.
Topics: Cell Survival; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; HEK293 Cells; Humans; Isocitrate Dehydrogenase; Molecular Docking Simulation; Molecular Structure; Mutation; Oxazolidinones; Pyrazines; Structure-Activity Relationship | 2017 |
Identification of novel allosteric inhibitors of mutant isocitrate dehydrogenase 1 by cross docking-based virtual screening.
Topics: Allosteric Site; Blood-Brain Barrier; Brain Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glioma; HEK293 Cells; Humans; Isocitrate Dehydrogenase; Molecular Docking Simulation; Molecular Structure; Mutation; Small Molecule Libraries; Structure-Activity Relationship | 2018 |